Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, ...

Insilico said the clinical evaluation of its idiopathic pulmonary fibrosis candidate, rentosertib, is the first featuring both an artificial intelligence-discovered target and an innovative ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

An experimental drug developed with the help of artificial intelligence (AI) has shown early signs that it could reduce markers of biological ageing while treating idiopathic pulmonary fibrosis (IPF), ...

When a drug fails a clinical trial, it may seem that years of research and development have gone to waste. A failed trial, ...

Spread the love“`html Imagine slashing years off the drug development timeline and saving billions in the process. Sounds ...

This listicle highlights real-world success stories in drug repurposing and emerging strategies involving genomics, clinical ...

NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal ...

On June 30, 2026, the National Institutes of Health announced that its All of Us Research Program has become the world’s largest integrated genomic and electronic health record database, with data ...

Drug repurposing — the identification of new therapeutic indications for approved drugs or clinical-stage candidates — offers one of the most efficient strategies to deliver new treatments to patients ...

Curative Biotechnology, founded by Paul Michaels, is one example of a company building its research model around that ...

The U.S. Food and Drug Administration (FDA) recently launched a drug repurposing initiative that may signal a shift in how the Agency approaches therapeutic development. Rather than focusing ...